Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prithi Raguraman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|April 19, 2022
Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in <i>mdx</i> mouse myotubesYongdong Su, Prithi Raguraman, Rakesh N Veedu, et al.
Biomedicines|December 23, 2023
Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer CellsAkilandeswari Ashwini Balachandran, Prithi Raguraman, Kamal Rahimizadeh, et al.
Bioorganic & Medicinal Chemistry|January 9, 2022
Oligonucleotides containing 2'-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitroAlejandro Gimenez Molina, Prithi Raguraman, Line Delcomyn, et al.
Cancers|November 13, 2021
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer MitigationPrithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen, et al.
International Journal of Molecular Sciences|April 5, 2020
Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In VitroPrithi Raguraman, Tao Wang, Lixia Ma, et al.
Molecular Therapy. Nucleic Acids|December 31, 2018
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer TherapeuticsBao T Le, Prithi Raguraman, Tamer R Kosbar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|April 19, 2022
Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in <i>mdx</i> mouse myotubesYongdong Su, Prithi Raguraman, Rakesh N Veedu, et al.
Biomedicines|December 23, 2023
Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer CellsAkilandeswari Ashwini Balachandran, Prithi Raguraman, Kamal Rahimizadeh, et al.
Bioorganic & Medicinal Chemistry|January 9, 2022
Oligonucleotides containing 2'-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitroAlejandro Gimenez Molina, Prithi Raguraman, Line Delcomyn, et al.
Cancers|November 13, 2021
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer MitigationPrithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen, et al.
International Journal of Molecular Sciences|April 5, 2020
Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In VitroPrithi Raguraman, Tao Wang, Lixia Ma, et al.
Molecular Therapy. Nucleic Acids|December 31, 2018
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer TherapeuticsBao T Le, Prithi Raguraman, Tamer R Kosbar, et al.
Pageof 1